VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, January 5, 2026
Stock Comparison
Legrand S.A. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Legrand S.A.
LR · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 68 / 100 for Legrand S.A.).
- Segment focus: Legrand S.A. has 2 segments (80% in Building electrical & digital infrastructure (non-datacenter)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Legrand S.A. has 4 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Legrand S.A.
Building electrical & digital infrastructure (non-datacenter)
Low-voltage electrical and digital building infrastructure (wiring devices, energy distribution, cable management, building controls)
Global (strong Europe & North America footprint)
Professional installers/electricians, electrical wholesalers, OEM/contractors; end-users in residential & commercial buildings
Manufacturer + brand owner; channel-driven distribution
80%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Legrand S.A. strengths
Sanofi strengths
Segment mix
Legrand S.A. segments
Full profile >Building electrical & digital infrastructure (non-datacenter)
Oligopoly
Datacenter infrastructure
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.